ANTHEM INC COM STK (IN)(ANTM)
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- Exchange
- XNYS
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | -1.33% | 2 |
| Feb | +1.68% | 2 |
| Mar | +2.08% | 2 |
| Apr | +6.77% | 2 |
| May | +0.24% | 2 |
| Jun | -5.85% | 2 |
| Jul | +0.23% | 1 |
| Aug | -3.16% | 1 |
| Sep | +2.88% | 1 |
| Oct | +14.78% | 1 |
| Nov | -6.89% | 1 |
| Dec | +12.59% | 1 |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Enter a ticker to render the implied volatility surface.
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2022-06-13 | Charles Morgan JR Kendrick | EVP & President, Commercial | Mixed | — | $387.06 | -$1.29M | EDGAR |
| 2022-06-07 | Robert L JR Dixon | Director | Sell (S) | −420 | $497.14 | -$208.8K | EDGAR |
| 2022-05-20 | Robert L JR Dixon | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | Bahija Jallal | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | Ryan M. Schneider | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | Elizabeth E Tallett | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | R KERRY CLARK | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | RAMIRO G PERU | Director | Mixed | −550 | $468.88 | -$464.2K | EDGAR |
| 2022-05-20 | LEWIS III HAY | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | Susan D. DeVore | Director | Award (A) | +440 | — | EDGAR | |
| 2022-05-20 | Antonio F Neri | Director | Award (A) | +440 | — | EDGAR | |
| 2022-03-14 | Peter D Haytaian | EVP & Pres., DBG & IngenioRx | Mixed | −15,855 | $429.62 | -$7.91M | EDGAR |
| 2022-03-03 | GAIL BOUDREAUX | President and CEO | Mixed | +19,501 | $452.66 | -$7.69M | EDGAR |
| 2022-03-03 | Felicia F Norwood | EVP & President, GBD | Mixed | +5,182 | $452.83 | -$1.82M | EDGAR |
| 2022-03-03 | Blair Williams Todt | EVP and Chief Legal Officer | Mixed | +1,692 | $451.50 | -$86.2K | EDGAR |
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joseph Swedish | President & CEO | 205,854 | $99.34M | $0 | 3 | 2015-04-03 |
| 2 | SAMUEL R MD NUSSBAUM | EVP & Chief Medical Officer | 110,972 | $53.55M | -$9.24M | 3 | 2015-05-13 |
| 3 | GAIL BOUDREAUX | President and CEO | 94,041 | $45.38M | $2.00M | 6 | 2022-03-03 |
| 4 | Kenneth R Goulet | EVP, Commercial & Specialty | 90,243 | $43.55M | -$10.31M | 2 | 2015-03-04 |
| 5 | Wayne S DeVeydt | EVP & Chief Financial Officer | 82,126 | $39.63M | -$18.37M | 3 | 2015-04-08 |
| 6 | GLORIA M MCCARTHY | EVP & Chief Administrative Off | 60,731 | $29.31M | -$23.12M | 14 | 2022-03-03 |
| 7 | John E Gallina | EVP & Chief Financial Officer | 46,857 | $22.61M | -$24.09M | 9 | 2022-03-03 |
| 8 | GEORGE A JR SCHAEFER | Director | 38,864 | $18.75M | $0 | 1 | 2018-05-18 |
| 9 | BRIAN T GRIFFIN | EVP & CEO, IngenioRx | 38,554 | $18.61M | -$13.33M | 1 | 2018-05-07 |
| 10 | Craig E Samitt | EVP & President, DBG | 36,815 | $17.77M | -$4.82M | 1 | 2018-07-27 |
| 11 | JULIE A HILL | Director | 31,213 | $15.06M | -$1.91M | 10 | 2021-05-24 |
| 12 | Jose D. Tomas | EVP & Chief HR Officer | 30,323 | $14.63M | $0 | 1 | 2015-03-04 |
| 13 | Martin B Silverstein | EVP & Chief Strategy Officer | 23,249 | $11.22M | $0 | 2 | 2015-05-05 |
| 14 | Felicia F Norwood | EVP & President, GBD | 21,903 | $10.57M | $0 | 11 | 2022-03-03 |
| 15 | THOMAS C ZIELINSKI | EVP & General Counsel | 17,910 | $8.64M | -$17.78M | 9 | 2020-11-04 |
| 16 | Prakash R Patel | EVP & President, DBG | 17,230 | $8.31M | $0 | 9 | 2021-09-08 |
| 17 | Charles Morgan JR Kendrick | EVP & President, Commercial | 15,257 | $7.36M | -$3.09M | 3 | 2022-06-13 |
| 18 | Peter D Haytaian | EVP & Pres., DBG & IngenioRx | 13,441 | $6.49M | -$56.89M | 28 | 2022-03-14 |
| 19 | LEAH STARK | EVP & CHRO | 12,403 | $5.99M | $0 | 6 | 2022-01-04 |
| 20 | RAMIRO G PERU | Director | 10,395 | $5.02M | -$2.29M | 9 | 2022-05-20 |
| 21 | LEWIS III HAY | Director | 10,061 | $4.86M | $0 | 5 | 2022-05-20 |
| 22 | Robert L JR Dixon | Director | 9,491 | $4.58M | -$1.14M | 9 | 2022-06-07 |
| 23 | Elizabeth E Tallett | Director | 9,446 | $4.56M | $0 | 5 | 2022-05-20 |
| 24 | R KERRY CLARK | Director | 8,194 | $3.95M | $0 | 5 | 2022-05-20 |
| 25 | Ryan M. Schneider | Director | 5,154 | $2.49M | $1.00M | 6 | 2022-05-20 |
| 26 | Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | 5,107 | $2.46M | $0 | 3 | 2021-10-04 |
| 27 | Antonio F Neri | Director | 3,479 | $1.68M | $0 | 5 | 2022-05-20 |
| 28 | Bahija Jallal | Director | 3,342 | $1.61M | $0 | 5 | 2022-05-20 |
| 29 | Ronald W Penczek | CAO & Controller | 3,204 | $1.55M | -$4.90M | 13 | 2022-03-03 |
| 30 | Blair Williams Todt | EVP and Chief Legal Officer | 2,534 | $1.22M | $0 | 4 | 2022-03-03 |
| 31 | Susan D. DeVore | Director | 856 | $413.1K | $0 | 2 | 2022-05-20 |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.